Expert opinions on the first-line pharmacological treatment for delirium in Japan: a conjoint analysis

International Psychogeriatrics
Yasuyuki OkumuraDELIRIA-J Group

Abstract

There is little expert consensus as to which drugs should comprise the first-line pharmacological treatment for delirium. We sought to assess experts' opinions on the first-line oral and injection drugs for delirium associated with a diverse range of clinical features using a rating-based conjoint analysis. We conducted a cross-sectional study. We mailed a questionnaire to all consultation-liaison psychiatrists/educators certified by the Japanese Society of General Hospital Psychiatry. Of 136 experts (response rate: 27.5%), more than 68% recommended the use of risperidone or quetiapine administered orally for hyperactive delirium, except in patients with comorbid diabetes and renal dysfunction. More than 67% recommended the use of haloperidol administered intravenously for hyperactive delirium if an intravenous line has been placed. No oral or injection drugs were recommended by over half of experts for treatment of hypoactive delirium with any clinical features. In the absence of a definitive treatment trial, there are both areas of agreement and a lack of consensus regarding the first-line drug. Efforts are needed to routinely collect information that would allow a comparison of the effectiveness and safety of various drugs i...Continue Reading

References

Jan 19, 1999·The American Journal of Psychiatry·A I Leshner
Aug 25, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·P T ThyrumC Yeh
Jul 10, 2001·Psychiatry and Clinical Neurosciences·T SomeyaJ Suzuki
Apr 24, 2004·Annals of General Hospital Psychiatry·Kimberly D McLaren, Lauren B Marangell
Oct 16, 2004·Journal of Clinical Pharmacy and Therapeutics·X S RenL E Kazis
May 6, 2006·Behavioral and Brain Functions : BBF·V SrinivasanR Hardeland
Jun 1, 2006·Expert Review of Neurotherapeutics·Naji Tabet, Robert Howard
Feb 28, 2007·Journal of Psychosomatic Research·Laurent MichaudUNKNOWN Delirium Guidelines Development Group
May 3, 2007·Psychiatry and Clinical Neurosciences·Shingo MiyajiHitoshi Miyaoka
Jan 16, 2008·Archives of Internal Medicine·Douglas L LeslieSharon K Inouye
Aug 21, 2008·Australasian Journal on Ageing·Joanne TropeaTony Snell
Apr 16, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Carla Meyer-MassettiB Joseph Guglielmo
Jun 10, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Emmanuel KingJeff Greenblatt
Jul 29, 2010·JAMA : the Journal of the American Medical Association·Joost WitloxWillem A van Gool
Jul 30, 2010·BMJ : British Medical Journal·John YoungUNKNOWN Guideline Development Group
Oct 20, 2010·Journal of Psychosomatic Research·Tayyeb A TahirJonathan I Bisson
May 18, 2012·Critical Care : the Official Journal of the Critical Care Forum·Joshua T SwanKrista L Turner
Jun 27, 2013·International Journal of Geriatric Psychiatry·Kotaro HattaHiroyuki Nakamura
Aug 22, 2013·International Psychogeriatrics·A MorandiA M MacLullich
Mar 22, 2014·International Journal of Impotence Research·R L SegalA L Burnett
Dec 24, 2014·Journal of the American College of Surgeons·UNKNOWN American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults
Jun 5, 2015·BMJ : British Medical Journal·Jorge I F SalluhRobert D Stevens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Advances in Psychosomatic Medicine
H Ishikawa
Advances in Psychosomatic Medicine
H Kurosawa, T Hosaka
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
Nitin GuptaSurendra K Mattoo
Hospital & Community Psychiatry
S B GelfandJ Benjamin
© 2022 Meta ULC. All rights reserved